JPH06128143A - External agent for skin - Google Patents

External agent for skin

Info

Publication number
JPH06128143A
JPH06128143A JP4278844A JP27884492A JPH06128143A JP H06128143 A JPH06128143 A JP H06128143A JP 4278844 A JP4278844 A JP 4278844A JP 27884492 A JP27884492 A JP 27884492A JP H06128143 A JPH06128143 A JP H06128143A
Authority
JP
Japan
Prior art keywords
extract
skin
mixed
added
asparagus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4278844A
Other languages
Japanese (ja)
Other versions
JP3170070B2 (en
Inventor
Akinobu Hayashi
昭伸 林
Tomeyoshi Suzuki
留佳 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP27884492A priority Critical patent/JP3170070B2/en
Publication of JPH06128143A publication Critical patent/JPH06128143A/en
Application granted granted Critical
Publication of JP3170070B2 publication Critical patent/JP3170070B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide an external agent for skin having excellent skin-beautifying effect, effective in preventing and ameliorating spots, freckles and the darkening of skin caused by sunburn, etc., and safely usable because of its stability and safety. CONSTITUTION:The external agent for skin contains (A) an asparagus extract and (B) (B1) N,N'-diacetylcystine dimethyl or (B2) one or more kinds of the extracts of plants selected from Coix laryma-jobi, Polygonum bistorta, Sophora angustifolia, hawthorn, hop, wild rose and Easter lily.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は美白効果に優れ、安定性
及び安全性の高い新規な皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel external preparation for skin which is excellent in whitening effect and has high stability and safety.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】従来、
皮膚の色黒、シミ、ソバカスの防止などの美容効果を得
る目的で美白化粧料が広く用いられており、このような
美白外用剤には美白薬剤として主にアスコルビン酸、グ
ルタチオン、コロイドイオウ等が配合されている。しか
しながら、アスコルビン酸は酸化を受けやすいため、一
定の効果の発現が期待し難く、またグルタチオンやコロ
イドイオウは特有の異臭及び沈澱等が生じるという欠点
があった。
2. Description of the Related Art Conventionally, the problems to be solved by the invention
Whitening cosmetics are widely used for the purpose of obtaining beauty effects such as preventing dark skin, stains, freckles, etc., and as such whitening agents, ascorbic acid, glutathione, colloidal sulfur, etc. are mainly used as whitening agents. It is compounded. However, since ascorbic acid is susceptible to oxidation, it is difficult to expect a certain effect to be exhibited, and glutathione and colloidal sulfur have a drawback that they have a peculiar offensive odor and precipitation.

【0003】このため、最近、広く自然界からの美白薬
剤の探究、例えば植物抽出物のスクリーニングが行われ
ており、その効果を有するいくつかの抽出物が確認され
ている。
Therefore, recently, whitening agents have been widely searched from the natural world, for example, screening of plant extracts, and some extracts having the effect have been confirmed.

【0004】しかしながら、この抽出物も、より高い美
白効果を期待して外用剤に高濃度に配合すると、製品の
安定性が低下する等、実際に使用するには充分満足でき
るものではなかった。このため、美白効果に優れ、しか
も安定性、安全性の高い皮膚外用剤が望まれていた。
However, this extract was not sufficiently satisfactory for actual use, since the stability of the product was lowered when it was blended in a high concentration in an external preparation in the expectation of a higher whitening effect. Therefore, there has been a demand for an external preparation for the skin which has excellent whitening effect, stability and safety.

【0005】[0005]

【課題を解決するための手段】斯かる実情において、本
発明者は鋭意研究を行った結果本発明を完成した。
Under the circumstances, the present inventor has completed the present invention as a result of earnest research.

【0006】すなわち、本発明は、次の成分(A)及び
(B)、(A)アスパラガス抽出物、(B)(イ)N,
N′−ジアセチルシスチンジメチル、又は(ロ)ヨクイ
ニン、イブキトラノオ、クララ、サンザシ、ホップ、ノ
イバラ及びシラユリから選ばれる植物の抽出物の1種又
は2種以上、を含有することを特徴とする皮膚外用剤を
提供するものである。
That is, the present invention provides the following components (A) and (B), (A) asparagus extract, (B) (A) N,
N'-diacetylcystine dimethyl, or (b) one or two or more kinds of plant extracts selected from Yokuinin, Ibukitoranoo, Clara, hawthorn, hop, Neubara and white lily, for external skin use The agent is provided.

【0007】本発明の皮膚外用剤に用いるアスパラガス
抽出物とは、アスパラガス(Asparagus of
ficinalis L.)の茎、根茎、葉、花などか
ら抽出して得られるものであり、その調製法は特に限定
されないが、例えば種々の適当な溶媒を用いて室温〜加
温下で抽出される。抽出溶媒としては、例えば水;メチ
ルアルコール、エチルアルコール等の低級一価アルコー
ル;グリセリン、プロピレングリコール、1,3−ブチ
レングリコール等の液状多価アルコール;酢酸エチル等
の低級アルキルエステル;ベンゼン、ヘキサン等の炭化
水素;ジエチルエーテル等のエーテル類等の一種又は二
種以上を用いることができる。特に水、エチルアルコー
ル、グリセリン、1,3−ブチレングリコールの一種又
は二種以上の混合溶媒が好ましい。また抽出条件として
は、アスパラガスに対し容量比で1〜1000倍量、特
に5〜100倍量の溶媒を用い、4℃以上、特に15〜
30℃の温度で1時間以上、特に1〜3日間行うのが好
ましい。
The asparagus extract used in the external preparation for skin of the present invention means asparagus of Asparagus of
ficinalis L .; (3) is obtained by extraction from the stem, rhizome, leaf, flower, etc., and its preparation method is not particularly limited. For example, it is extracted at room temperature to under heating using various suitable solvents. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; benzene and hexane. Hydrocarbons: One kind or two or more kinds of ethers such as diethyl ether can be used. In particular, water, ethyl alcohol, glycerin, and a mixed solvent of one or more kinds of 1,3-butylene glycol are preferable. As the extraction conditions, a solvent is used in a volume ratio of 1 to 1000 times, particularly 5 to 100 times, that of asparagus, at 4 ° C. or higher, particularly 15 to
It is preferable to carry out the treatment at a temperature of 30 ° C. for 1 hour or longer, particularly 1 to 3 days.

【0008】以上のような条件で得られる抽出物は、抽
出された溶液のまま用いても良いが、さらに必要により
濃縮、ろ過等の処理をしたものを適宜使い分けて用いる
ことができる。
The extract obtained under the above conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to treatments such as concentration and filtration, and used properly.

【0009】本発明の皮膚外用剤におけるアスパラガス
抽出物の配合量は、乾燥固形分に換算して0.0001
〜10.0重量%(以下、単に「%」で示す)が好まし
く、特に0.01〜5.0%の範囲が好ましい。含有量
が0.0001%未満であると効果が十分に発揮され
ず、10.0%を超えてもそれ以上の効果の増大は見ら
れない。
The compounding amount of the asparagus extract in the external preparation for skin of the present invention is 0.0001 in terms of dry solid content.
-10.0% by weight (hereinafter simply referred to as "%") is preferable, and a range of 0.01-5.0% is particularly preferable. If the content is less than 0.0001%, the effect is not sufficiently exhibited, and if it exceeds 10.0%, no further increase in the effect is observed.

【0010】本発明の(B)成分の(イ)のN,N′−
ジアセチルシスチンジメチルは、次の構造式
The N, N'- of the component (B) of the component (B) of the present invention.
Diacetylcystine dimethyl has the following structural formula

【0011】[0011]

【化1】 [Chemical 1]

【0012】で表わされるものであり、皮膚に容易に吸
収され、シスチン及びシステインに変換され、皮膚賦活
作用、美白作用を示すことが知られている(皮膚科の臨
(6)p.444)。本発明において、このN,
N′−ジアセチルシスチンジメチルは、全組成物中に
0.0001〜5%、特に0.01〜3.0%配合する
のが好ましい。0.0001%未満では充分な美白効果
が得られず、5%を超えると製品の安定性が低下するた
め好ましくない。
It is known that it is easily absorbed by the skin, converted into cystine and cysteine, and exhibits a skin activating action and a whitening action (Clinical Dermatology 9 (6) p. 444). ). In the present invention, this N,
N'-diacetylcystine dimethyl is preferably contained in the total composition in an amount of 0.0001 to 5%, particularly 0.01 to 3.0%. If it is less than 0.0001%, a sufficient whitening effect cannot be obtained, and if it exceeds 5%, the stability of the product decreases, which is not preferable.

【0013】本発明の(B)成分の(ロ)の植物抽出物
のうち、ヨクイニン抽出物は、イネ科のハトムギ(Co
ix lacryma−jobi L.var.ma−
yuen(ROMAM)STAPF)の種皮を除いた種
子等から抽出して得られるものである。また、イブキト
ラノオ、クララ、サンザシ、ホップ、ノイバラ、シラユ
リの抽出物は、植物の使用部は特に限定されず、これら
それぞれの葉、枝、茎、花、果実、根などを用い抽出す
ることができるが、就中、イブキトラノオは根茎、クラ
ラは根、サンザシ、ノイバラは果実、ホップは花、シラ
ユリは鱗茎が好ましい。
Among the plant extracts of (B) of the component (B) of the present invention, the Yokuinin extract is an adlay (Co) of the Poaceae family.
ix lacryma-jobi L. var. ma-
yuen (ROMAM) STAPF) obtained by extracting from seeds and the like excluding the seed coat. Further, the extract of Ibukitoranoo, Clara, hawthorn, hops, Neubara, white lily, the use part of the plant is not particularly limited, and these leaves, branches, stems, flowers, fruits, roots and the like can be extracted. However, among others, rhizomes for Ibukitoranoo, roots for Clara, hawthorn, fruits of hawthorn, fruits for hops, flowers for white lily, and bulbs for white lily are preferable.

【0014】抽出方法は特に限定されないが、例えば種
々の適当な溶媒を用いて室温又は加温下で抽出すること
ができる。抽出溶媒としては、例えば水;メチルアルコ
ール、エチルアルコール等の低級一価アルコール;プロ
ピレングリコール、1,3−ブチレングリコール等の液
状多価アルコール;酢酸エチル等の低級アルキルエステ
ル;ベンゼン、ヘキサン等の炭化水素;ジエチルエーテ
ル等のエーテル類等の1種又は2種以上を用いることが
できる。これらのうちでも、水又は水溶性溶媒、特に
水、エチルアルコール、グリセリン、1,3−ブチレン
グリコールの1種又は2種以上の混合溶媒が好ましい。
The extraction method is not particularly limited, but it can be extracted, for example, at room temperature or under heating using various suitable solvents. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as propylene glycol and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; carbonization such as benzene and hexane. Hydrogen; one or more ethers such as diethyl ether may be used. Among these, water or a water-soluble solvent, particularly water, ethyl alcohol, glycerin, 1,3-butylene glycol, or a mixed solvent of two or more thereof is preferable.

【0015】以上のような条件で得られる植物抽出物
は、抽出された溶液のまま用いてもよいが、さらに必要
により濃縮、ろ過等の処理をしたものを適宜使い分けて
用いることができる。
The plant extract obtained under the above-mentioned conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to treatment such as concentration and filtration, and may be appropriately used.

【0016】これら(B)成分の植物抽出物は、単独又
は2種以上を組合せて用いることができ、全組成中に固
形分として0.0001〜10.0%、特に0.001
〜5.0%配合するのが好ましい。0.0001%未満
では充分な美白効果が得られず、10.0%を超えて配
合してもその効果は増大せず、また抽出物によっては製
品の着色等の問題が生じることがあり好ましくない。
These plant extracts of the component (B) can be used alone or in combination of two or more kinds, and 0.0001 to 10.0%, particularly 0.001 as solid content in the whole composition.
It is preferable to mix it up to 5.0%. If it is less than 0.0001%, a sufficient whitening effect cannot be obtained, and if it exceeds 10.0%, the effect does not increase, and depending on the extract, problems such as coloring of the product may occur. Absent.

【0017】さらに、本発明の皮膚外用剤には、本発明
の効果を損なわない範囲で、前記必須成分の他に、通常
の皮膚外用剤に用いられる水性成分、粉体、界面活性
剤、油剤、保湿剤、アルコール類、pH調整剤、防腐剤、
色素、酸化防止剤、紫外線吸収剤、増粘剤、香料、美容
成分等を必要に応じて適宜配合することができる。
Further, the external preparation for skin of the present invention contains, in addition to the above-mentioned essential components, aqueous components, powders, surfactants and oils used in ordinary external preparations for skin, as long as the effects of the present invention are not impaired. , Moisturizers, alcohols, pH adjusters, preservatives,
Dyes, antioxidants, ultraviolet absorbers, thickeners, fragrances, cosmetic ingredients and the like can be appropriately added as necessary.

【0018】本発明の皮膚外用剤は、必須成分である前
述の(A)成分と(B)成分とを配合し、常法に従って
製造することができ、乳液、クリーム、化粧水、美容
液、クレンジング、パック、洗浄料、ファンデーション
や、その他分散状、顆粒状、軟膏状等の医薬用、医薬部
外用又は化粧用の皮膚外用剤等として適用することがで
きる。
The external preparation for skin of the present invention can be manufactured by a conventional method by mixing the above-mentioned components (A) and (B), which are essential components, and can be manufactured by a conventional method. It can be applied as a cleansing, pack, detergent, foundation, and other external medicines for dispersion, granules, ointments, etc. for medicine, quasi-drugs or cosmetics.

【0019】[0019]

【実施例】次に試験例及び実施例を挙げて本発明をさら
に詳細に説明するが、本発明はこれらに限定されるもの
ではない。
The present invention will be described in more detail with reference to Test Examples and Examples, but the present invention is not limited to these.

【0020】試験例1 チロシナーゼ活性阻害試験: <試料> アスパラガス抽出物:原料として生ホワイトアスパラガ
ス根本部分を23650g(新鮮重量として)計量し、
次いでアルコール濃度が60%となるように調整してエ
タノールを添加した。これらを食品用ミキサー(ナショ
ナルMX−M3)を用いて粉砕して、混合物を得た。次
いでこれらの原料と溶媒からなる混合物をポリバケツに
入れて、室温下、一昼夜静置して抽出を行った後、吸引
ろ過により抽出液を吸引ろ過ビンに回収した。抽出残渣
には再度60%エタノールを25l加え、前述の操作を
繰り返した後、抽出液約66lをロータリーエバポレー
ターにより濃縮、溶媒留去して褐色の濃縮抽出物を10
00g(乾燥固形分4%)得た(第1工程)。
Test Example 1 Tyrosinase activity inhibition test: <Sample> Asparagus extract: Raw white asparagus root portion was weighed at 23650 g (as fresh weight) as a raw material,
Next, ethanol was added after adjusting the alcohol concentration to 60%. These were ground using a food mixer (National MX-M3) to obtain a mixture. Then, a mixture consisting of these raw materials and a solvent was placed in a poly bucket and allowed to stand at room temperature for one day for extraction, and then the extract was collected by suction filtration into a suction filtration bottle. To the extraction residue, 25 liters of 60% ethanol was added again, the above operation was repeated, and about 66 liters of the extract was concentrated by a rotary evaporator and the solvent was distilled off to obtain a brown concentrated extract.
00 g (dry solid content 4%) was obtained (first step).

【0021】次いで該濃縮抽出物が全て溶解する迄、n
−ブタノールと水(1:1)の混合溶媒を加え、よく振
とうした後、遠心分離機で約1万回転、30分間の遠心
分離を行って、サポニン成分等をn−ブタノール層に抽
出分離した(第2工程)。次いで該n−ブタノール層
を、ロータリーエバポレーターにより濃縮、溶媒留去し
て約110gの抽出物を得た(第3工程)。
Then, until the concentrated extract is completely dissolved, n
-Add a mixed solvent of butanol and water (1: 1), shake well, and then centrifuge for about 30 minutes with a centrifuge for about 30 minutes to extract and separate saponin components and the like into an n-butanol layer. (Second step). Then, the n-butanol layer was concentrated by a rotary evaporator and the solvent was distilled off to obtain about 110 g of an extract (third step).

【0022】次いで該エキスに水とベンゼンを当量ずつ
加えて懸濁させ、乳白色の溶液を得た。この溶液を遠心
分離機を用いて1万回転、30分間の処理条件で遠心分
離し、分離したベンゼン層を遠心管を傾け上層のベンゼ
ンを捨てるか、或いはピペット管で上層だけを吸い取っ
て取り除くと共に抽出物中の脂質成分の除去を行い、さ
らに残った水層部に、新たなベンゼンを同量加えて同様
な操作を行った。該脱脂工程は、ベンゼンだけの添加だ
けでも良いが、クロロホルムやエーテルのような他の溶
媒を用いると効率良い脱脂が行えることを確認している
(第4工程)。
Next, water and benzene were added to the extract in equivalent amounts to suspend the extract, to obtain a milky white solution. This solution was centrifuged at 10,000 rpm for 30 minutes using a centrifuge, and the separated benzene layer was tilted by centrifuging the centrifuge tube to discard the benzene in the upper layer, or by sucking off only the upper layer with a pipette tube. The lipid component in the extract was removed, and the same amount of new benzene was added to the remaining aqueous layer, and the same operation was performed. The degreasing step may be performed by adding only benzene, but it has been confirmed that efficient degreasing can be performed by using another solvent such as chloroform or ether (fourth step).

【0023】次いで得られた水層部分より、ロータリー
エバポレーターによって水分を濃縮、乾固した後、n−
ブタノールと水(1:1)の混合溶媒約1lを添加して
抽出物を溶解させ、分液ロート内で一昼夜静置してサポ
ニン成分をブタノール層に抽出した。次いでブタノール
層を、ロータリーエバポレーターにより濃縮、乾固して
約18gの抽出物(褐色エキス)を得た(第5工程)。
Next, water is concentrated from the obtained aqueous layer portion by a rotary evaporator and dried to dryness, and then n-
About 1 liter of a mixed solvent of butanol and water (1: 1) was added to dissolve the extract, and the saponin component was extracted into the butanol layer by allowing the mixture to stand in a separating funnel for one day. Then, the butanol layer was concentrated by a rotary evaporator and dried to obtain about 18 g of extract (brown extract) (fifth step).

【0024】次いで該褐色抽出物に300mlのメタノー
ルを加えて溶解し、注射針を用いて75mlずつ、別に用
意したエチルエーテル(2l)の中にゆっくり滴下させ
て白色の沈殿を生成せしめ、しばらく静置させた後、傾
潟法によりエーテルを大部分除去し、さらに吸引ろ過に
より沈殿を集め、その沈殿物の上から新しいエーテルで
数回洗って、夾雑物の溶けたエーテルを洗い流した。こ
のような操作で得られたほぼ白色の沈殿物を、真空デシ
ケータ中で乾燥した後、乳鉢で粉砕して、約11gのア
スパラガスサポニン粉末を得た(第6工程)。
Then, 300 ml of methanol was added to the brown extract to dissolve it, and 75 ml of each was slowly dropped into a separately prepared ethyl ether (2 l) using an injection needle to form a white precipitate, which was allowed to stand for a while. After leaving it for a long time, most of the ether was removed by the gradient method, the precipitate was collected by suction filtration, and the precipitate was washed several times with fresh ether to wash away the dissolved ether of the contaminants. The almost white precipitate obtained by such an operation was dried in a vacuum desiccator and then ground in a mortar to obtain about 11 g of asparagus saponin powder (sixth step).

【0025】尚本試験例においては、上記第1工程で得
られたアスパラガス抽出物を使用した。
In this test example, the asparagus extract obtained in the first step was used.

【0026】ヨクイニン抽出物:ヨクイニン抽出液(丸
善製薬社製) イブキトラノオ抽出物:イブキトラノオ抽出液(A.
M.I社製) クララ抽出物:クジン抽出液(丸善製薬社製) サンザシ抽出物:サンザシ抽出液(丸善製薬社製) ホップ抽出物:ホップ抽出液(丸善製薬社製) ノイバラ抽出物:ハーベックスノバラ抽出液(香栄興業
社製) シラユリ抽出物:白百合抽出液GR−327(丸善製薬
社製)
Yokuinin extract: Yokuinin extract (manufactured by Maruzen Pharmaceutical Co., Ltd.) Ibuquitranoo extract: Ibukitranoo extract (A.
M. Company I) Clara extract: Kujin extract (Maruzen Pharmaceutical Co., Ltd.) Hawthorn extract: Hawthorn extract (Maruzen Pharmaceutical Co., Ltd.) Hop extract: Hop extract (Maruzen Pharmaceutical Co., Ltd.) Neubara extract: Harbex Novara Extract (Koei Kogyo Co., Ltd.) Shirayuri extract: Shirayuri extract GR-327 (Maruzen Pharmaceutical Co., Ltd.)

【0027】<測定方法>各試料に酵素溶液〔シグマ社
製、28,000単位のチロシナーゼ10mgを0.1M
リン酸緩衝液(pH6.8)20mlに溶解したもの〕0.
1mlを加え、さらに0.1Mリン酸緩衝液(pH6.8)
を加え4mlとし、これを25℃にて10分間インキュベ
ートした。これに、あらかじめ25℃に保っておいた基
質溶液〔L−DOPA(東京化成)198.0mgを0.
1Mリン酸緩衝液(pH6.8)100mlに溶解したも
の〕1.0mlを加え、10分間反応せしめた。次いで4
75nmにおける吸光度(ODs)を測定した。さらに加
熱失活させた前記酵素を用いて同様に反応させた吸光度
(ODHE)及び試料無添加のときの吸光度(ODB)を
測定し、次式よりチロシナーゼ活性の活性阻害率を算出
した。
<Measuring method> An enzyme solution [manufactured by Sigma, 28,000 units of tyrosinase (10 mg)]
Dissolved in 20 ml of phosphate buffer (pH 6.8)]
Add 1 ml and add 0.1M phosphate buffer (pH 6.8)
Was added to make 4 ml, and this was incubated at 25 ° C. for 10 minutes. A substrate solution [L-DOPA (Tokyo Kasei) 198.0 mg, which had been kept at 25 ° C. in advance, was added to this.
1.0 ml of a solution dissolved in 100 ml of 1 M phosphate buffer (pH 6.8) was added and reacted for 10 minutes. Then 4
Absorbance (OD s ) at 75 nm was measured. Further, the absorbance (OD HE ) of the same reaction using the enzyme deactivated by heating and the absorbance (OD B ) when no sample was added were measured, and the activity inhibition rate of tyrosinase activity was calculated from the following formula.

【0028】[0028]

【数1】 [Equation 1]

【0029】結果を表1及び2に示す。The results are shown in Tables 1 and 2.

【0030】[0030]

【表1】 [Table 1]

【0031】[0031]

【表2】 [Table 2]

【0032】表1及び2から明らかな如く、(A)及び
(B)成分を組合せた場合には、それぞれを単独で用い
た場合よりチロシナーゼ活性阻害作用が高く、相乗的な
美白効果を示した。
As is clear from Tables 1 and 2, when the components (A) and (B) were combined, the tyrosinase activity inhibitory action was higher than when they were used alone, and a synergistic whitening effect was exhibited. .

【0033】実施例1 乳液:表3に示す組成の乳液
を製造し、美白効果について評価した。結果を表4に示
す。
Example 1 Emulsion: An emulsion having the composition shown in Table 3 was prepared and evaluated for its whitening effect. The results are shown in Table 4.

【0034】[0034]

【表3】 [Table 3]

【0035】<製法> A.(6)〜(11)、(15)及び(16)を加熱混
合し、70℃に保つ。 B.(1)〜(5)、(12)及び(13)を加熱混合
し、70℃に保つ。 C.BをAに加えて混合し、さらに(14)を加え、均
一に乳化し、30℃まで冷却して乳液を得る。
<Production Method> A. (6) to (11), (15) and (16) are mixed by heating and kept at 70 ° C. B. (1) to (5), (12) and (13) are mixed by heating and kept at 70 ° C. C. B is added to A and mixed, and (14) is further added to emulsify uniformly and cooled to 30 ° C. to obtain an emulsion.

【0036】<美白効果試験>23〜44才の女性15
名をパネルとし、毎日、朝と夜の2回、洗顔後に試料1
6〜23の乳液を、各人4品ずつ、それぞれ、適量顔面
に12週間にわたって塗布することにより、使用テスト
を行い、次の基準で評価した。
<Whitening effect test> Women aged 23 to 44 years 15
Name the panel, and sample 1 after washing the face twice daily, morning and night
The use test was performed by applying an appropriate amount of each of the 6 to 23 milky lotions to each face for 12 weeks, and evaluated according to the following criteria.

【0037】評価基準; 有 効:シミ、ソバカスが目立たなくなった。 やや有効:シミ、ソバカスがあまり目立たなくなった。 無 効:変わらない。Evaluation Criteria: Effective: Spots and freckles became inconspicuous. Slightly effective: Spots and freckles are less noticeable. Ineffective: No change.

【0038】[0038]

【表4】 [Table 4]

【0039】表4から明らかな如く、成分(A)及び
(B)を組合せて配合した本発明の乳液(試料21〜2
3)は、これらを全く含まない試料16と比較した場合
はもとより、成分(A)又は(B)を単独で配合した試
料17〜20と比べても、シミ・ソバカスを目立たなく
する効果に優れ、顕著な美白効果を示した。
As is apparent from Table 4, the emulsion of the present invention (Samples 21 to 2) prepared by combining the components (A) and (B) in combination.
3) is excellent in the effect of making spots and freckles inconspicuous not only when compared with Sample 16 which does not contain any of these, but also when compared with Samples 17 to 20 in which the component (A) or (B) is blended alone. , Showed a remarkable whitening effect.

【0040】[0040]

【表5】 実施例2 化粧料: <処方> (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレンソルビタンモノラウリン酸 エステル(20E.O.) 1.2 (4)エチルアルコール 8.0 (5)センブリ抽出物(乾燥固形分として) 0.01 (6)アスパラガス抽出物*1 2.0 (7)ヨクイニン抽出物*2(乾燥固形分として) 0.05 (8)防腐剤 適量 (9)香料 適量 (10)精製水 残量Table 2 Example 2 Cosmetics: <Prescription> (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene sorbitan monolaurate ester (20E.O. ) 1.2 (4) Ethyl alcohol 8.0 (5) Yellowtail extract (as dry solids) 0.01 (6) Asparagus extract * 1 2.0 (7) Yokuinin extract * 2 (Dry solids) As a minute) 0.05 (8) Preservative Suitable amount (9) Perfume Suitable amount (10) Purified water Remaining amount

【0041】<製法> A.(3)、(4)、(8)及び(9)を混合溶解す
る。 B.(1)、(2)、(5)〜(7)及び(10)を混
合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
<Production Method> A. (3), (4), (8) and (9) are mixed and dissolved. B. (1), (2), (5) to (7) and (10) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0042】[0042]

【表6】 実施例3 クリーム: <処方> (%) (1)ミツロウ 6.0 (2)セタノール 5.0 (3)還元ラノリン 5.0 (4)スクワラン 30.0 (5)グリセリンモノステアレート 4.0 (6)親油性モノステアリン酸グリセリル 2.0 (7)ポリオキシエチレンソルビタンモノラウリン酸 エステル(20E.O.) 2.0 (8)アスパラガス抽出物*1 1.0 (9)ヨクイニン抽出物*2(乾燥固形分として) 0.2 (10)防腐剤 0.3 (11)香料 0.05 (12)精製水 残量Table 6 Example 3 Cream: <Prescription> (%) (1) Beeswax 6.0 (2) Cetanol 5.0 (3) Reduced lanolin 5.0 (4) Squalane 30.0 (5) Glycerin monostea Rate 4.0 (6) Lipophilic glyceryl monostearate 2.0 (7) Polyoxyethylene sorbitan monolaurate ester (20 EO) 2.0 (8) Asparagus extract * 1 1.0 (9) Yokuinin extract * 2 (as dry solids) 0.2 (10) Preservative 0.3 (11) Perfume 0.05 (12) Purified water Remaining amount

【0043】<製法> A.(1)〜(7)、(10)及び(11)を混合し、
加熱して70℃に保つ。 B.(8)、(9)及び(12)を混合し、加熱して7
0℃に保つ。 C.AにBを加え、混合した後、冷却してクリームを得
た。
<Production Method> A. (1) to (7), (10) and (11) are mixed,
Heat and keep at 70 ° C. B. Mix (8), (9) and (12) and heat to 7
Keep at 0 ° C. C. B was added to A, mixed, and then cooled to obtain a cream.

【0044】[0044]

【表7】 実施例4 パック: <処方> (%) (1)ポリビニルアルコール 20.0 (2)エタノール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)アスパラガス抽出物*1 0.1 (6)ヨクイニン抽出物*2 2.0 (7)防腐剤 0.3 (8)香料 0.1 (9)精製水 残量Table 4 Example 4 Pack: <Formulation> (%) (1) Polyvinyl alcohol 20.0 (2) Ethanol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Asparagus extraction * 1 0.1 (6) Yokuinin extract * 2 2.0 (7) Preservative 0.3 (8) Perfume 0.1 (9) Purified water Remaining amount

【0045】<製法> A.(1)、(3)〜(6)及び(9)を混合し、70
℃に加熱し、攪拌する。 B.(2)、(7)及び(8)を混合する。 C.AにBを加え、混合した後、冷却してパックを得
た。
<Production Method> A. (1), (3) to (6) and (9) are mixed to obtain 70
Heat to ℃ and stir. B. Mix (2), (7) and (8). C. B was added to A, mixed, and then cooled to obtain a pack.

【0046】[0046]

【表8】 実施例5 洗浄料: <処方> (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 0.1 (8)防腐剤 0.2 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)アスパラガス抽出物*1 0.2 (12)ヨクイニン抽出物*2(乾燥固形分として) 0.01 (13)精製水 残量Table 5 Example 5 Cleaning agent: <Formulation> (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) ) Oleyl alcohol 1.5 (6) Purified lanolin 1.0 (7) Perfume 0.1 (8) Preservative 0.2 (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Asparagus Extract * 1 0.2 (12) Yokuinin extract * 2 (as dry solids) 0.01 (13) Purified water Remaining amount

【0047】<製法> A.(9)、(10)及び(13)を混合し、70℃に
加熱する。 B.(1)〜(6)及び(8)を混合し、70℃に加熱
する。 C.AにBを加え、暫く70℃に保ち、けん化反応が終
了してから、50℃まで冷却し、(7)、(11)及び
(12)を加え、冷却して洗浄料を得た。
<Production Method> A. Mix (9), (10) and (13) and heat to 70 ° C. B. Mix (1) to (6) and (8) and heat to 70 ° C. C. B was added to A and maintained at 70 ° C. for a while, and after the saponification reaction was completed, it was cooled to 50 ° C., (7), (11) and (12) were added and cooled to obtain a cleaning agent.

【0048】実施例6 表9に示す組成の乳液を製造し、美白効果について評価
した。結果を表10及び表11に示す。
Example 6 An emulsion having the composition shown in Table 9 was produced and evaluated for its whitening effect. The results are shown in Tables 10 and 11.

【0049】[0049]

【表9】 [Table 9]

【0050】<製法> A.(6)〜(9)及び(14)を加熱混合し、70℃
に保つ。 B.(1)〜(5)、(10)及び(11)を加熱混合
し、70℃に保つ。 C.BをAに加えて混合し、さらに(12)を加え均一
に混和した後(13)を加えて均一に乳化し、30℃ま
で冷却して乳液を得る。
<Production Method> A. (6) to (9) and (14) are heated and mixed, and the temperature is 70 ° C.
Keep on. B. (1) to (5), (10) and (11) are mixed by heating and kept at 70 ° C. C. B is added to A and mixed, and then (12) is added and uniformly mixed, then (13) is added and uniformly emulsified, and cooled to 30 ° C. to obtain an emulsion.

【0051】試験例2 有色モルモットの背部を剃毛し、麻酔下、紫外線を照射
すると色素沈着を生じることを利用して、被験物質の美
白効果を検討した。紫外線照射は、東芝(株)製FL2
0S・BLBランプとFL20S・E30ランプを3本
ずつ同時に照射し、紫外線量は4.8×106 erg/cm2
とした。紫外線照射の24時間前と照射直後及び照射2
4時間後に、モルモット背部の4か所(2×2cm)に、
試料24〜27を0.2mlずつよくすりこんだ。但し、
照射の前には、塗布部位を温水でよく洗浄した。照射の
7日後に各部位の色素沈着の程度を観察し、以下の基準
で判定した。結果を表10に示す。
Test Example 2 The whitening effect of a test substance was examined by utilizing the fact that the back of a colored guinea pig was shaved and the pigmentation was caused by irradiation with ultraviolet rays under anesthesia. UV irradiation is FL2 made by Toshiba Corporation
Three 0S / BLB lamps and three FL20S / E30 lamps are irradiated at the same time, and the amount of ultraviolet rays is 4.8 × 10 6 erg / cm 2
And 24 hours before UV irradiation, immediately after irradiation, and irradiation 2
After 4 hours, in 4 places (2 x 2 cm) on the back of the guinea pig,
Samples 24-27 were rubbed well in 0.2 ml increments. However,
Prior to irradiation, the application site was thoroughly washed with warm water. Seven days after the irradiation, the degree of pigmentation at each site was observed and judged according to the following criteria. The results are shown in Table 10.

【0052】<評価基準> 色素沈着評点; 0:色素沈着が全くみられない。 1:ごくわずか色素沈着が認められる。 2:色素沈着が認められるが、非照射部位との境界は不
明瞭。 3:色素沈着が認められ、非照射部位との境界が鮮明で
ある。 美白効果; 色素沈着評点が1点以下のモルモットが10匹中 8匹以上:著 効 6匹以上:有 効 4匹以上:やや有効 3匹以下:無 効
<Evaluation criteria> Pigmentation evaluation score: 0: No pigmentation is observed. 1: Very slight pigmentation is observed. 2: Pigmentation is observed, but the boundary with the non-irradiated site is unclear. 3: Pigmentation was observed, and the boundary with the non-irradiated site was clear. Whitening effect; Pigmentation score of 1 or less out of 10 guinea pigs: 8 or more: excellent effect 6 or more: effective 4 or more: moderately effective 3 or less: ineffective

【0053】[0053]

【表10】 [Table 10]

【0054】表10から明らかな如く、成分(A)及び
(B)を組合せて配合した本発明の乳液(試料27)
は、これらを全く含まない試料24と比較した場合はも
とより、それぞれを単独で配合した試料25、26と比
べても、顕著な色素沈着防止効果を示した。
As is apparent from Table 10, the emulsion of the present invention containing the components (A) and (B) in combination (Sample 27).
Shows a remarkable pigmentation-preventing effect not only when compared to Sample 24 which does not contain any of these, but also when compared to Samples 25 and 26 in which each of them is blended alone.

【0055】試験例3 使用効果試験 23〜44才の女性15名をパネルとし、毎日、朝と夜
の2回、洗顔後に試料24〜27の乳液を、それぞれ適
量顔面に12週間にわたって塗布することにより、使用
テストを行い、次の基準で評価した。 評価基準; 有 効:シミ・ソバカスが目立たなくなった。 やや有効:シミ・ソバカスがあまり目立たなくなった。 無 効:変わらない。
Test Example 3 Use-effect test 15 women aged 23 to 44 years were used as a panel, and each day, twice a day in the morning and at night, and after washing the face, the emulsions of Samples 24 to 27 were applied to the face in appropriate amounts for 12 weeks. According to the above, a usage test was conducted and evaluated according to the following criteria. Evaluation criteria; Effective: Spots and freckles are not noticeable. Slightly effective: Spot freckles are less noticeable. Ineffective: No change.

【0056】[0056]

【表11】 [Table 11]

【0057】表11から明らかな如く、本発明の乳液
(試料27)は、これらを全く含まない試料24と比較
した場合はもとより、それぞれを単独で配合した試料2
5、26と比べても、シミ・ソバカスを目立たなくする
効果に優れ、顕著な美白効果を示した。
As is clear from Table 11, the emulsion of the present invention (Sample 27) was not only compared with Sample 24 containing no such emulsion, but also Sample 2 in which each of them was blended alone.
Compared with Nos. 5 and 26, the effect of making spots and freckles inconspicuous was excellent and a remarkable whitening effect was exhibited.

【0058】[0058]

【表12】 実施例7 化粧水: <処方> (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレンソルビタンモノラウリン酸 エステル(20E.O.) 1.2 (4)エチルアルコール 8.0 (5)センブリ抽出物(乾燥固形分として) 0.01 (6)アスパラガス抽出物*1 2.0 (7)N,N′−ジアセチルシスチンジメチル 0.2 (8)防腐剤 適量 (9)香料 適量 (10)精製水 残量Table 7 Example 7 Lotion: <Prescription> (%) (1) Glycerin 5.0 (2) 1,3-Butylene glycol 6.5 (3) Polyoxyethylene sorbitan monolaurate ester (20E.O. ) 1.2 (4) Ethyl alcohol 8.0 (5) Assembly extract (as dry solids) 0.01 (6) Asparagus extract * 1 2.0 (7) N, N'-diacetylcystine dimethyl 0.2 (8) Preservative Suitable amount (9) Perfume Suitable amount (10) Purified water Remaining amount

【0059】<製法> A.(3)、(4)、(8)及び(9)を混合溶解す
る。 B.(1)、(2)、(5)〜(7)及び(10)を混
合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
<Production Method> A. (3), (4), (8) and (9) are mixed and dissolved. B. (1), (2), (5) to (7) and (10) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0060】[0060]

【表13】 実施例8 クリーム: <処方> (%) (1)ミツロウ 6.0 (2)セタノール 5.0 (3)還元ラノリン 5.0 (4)スクワラン 30.0 (5)グリセリンモノステアレート 4.0 (6)親油型モノステアリン酸グリセリル 2.0 (7)ポリオキシエチレンソルビタンモノラウリン酸 エステル(20E.O.) 2.0 (8)アスパラガス抽出物*1 1.0 (9)N,N′−ジアセチルシスチンジメチル 1.0 (10)イノシトール 0.1 (11)防腐剤 0.3 (12)香料 0.05 (13)精製水 残量Table 8 Example 8 Cream: <Formulation> (%) (1) Beeswax 6.0 (2) Cetanol 5.0 (3) Reduced lanolin 5.0 (4) Squalane 30.0 (5) Glycerin monostea Rate 4.0 (6) Lipophilic glyceryl monostearate 2.0 (7) Polyoxyethylene sorbitan monolaurate ester (20 EO) 2.0 (8) Asparagus extract * 1 1.0 (9 ) N, N'-Diacetylcystine dimethyl 1.0 (10) Inositol 0.1 (11) Preservative 0.3 (12) Perfume 0.05 (13) Purified water Remaining amount

【0061】<製法> A.(1)〜(7)、(11)及び(12)を混合し、
加熱して70℃に保つ。 B.(8)〜(10)及び(13)を混合し、加熱して
70℃に保つ。 C.AにBを加え、混合した後、冷却してクリームを得
た。
<Production Method> A. (1) to (7), (11) and (12) are mixed,
Heat and keep at 70 ° C. B. Mix (8) to (10) and (13), heat and keep at 70 ° C. C. B was added to A, mixed, and then cooled to obtain a cream.

【0062】[0062]

【表14】 実施例9 パック: <処方> (%) (1)ポリビニルアルコール 20.0 (2)エタノール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)ローズマリー抽出液(丸善製薬社製)(乾燥固形分として)0.02 (6)アスパラガス抽出物*1 0.1 (7)N,N′−ジアセチルシスチンジメチル 0.2 (8)防腐剤 0.3 (9)香料 0.1 (10)精製水 残量Table 14 Example 9 Pack: <Formulation> (%) (1) Polyvinyl alcohol 20.0 (2) Ethanol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Rosemary extraction Liquid (Maruzen Pharmaceutical Co., Ltd.) (as dry solids) 0.02 (6) Asparagus extract * 1 0.1 (7) N, N'-diacetylcystine dimethyl 0.2 (8) Preservative 0.3 (9) Perfume 0.1 (10) Purified water Remaining amount

【0063】<製法> A.(1)、(3)〜(7)及び(10)を混合し、7
0℃に加熱し、攪拌する。 B.(2)、(8)及び(9)を混合する。 C.AにBを加え、混合した後、冷却してパックを得
た。
<Production Method> A. Mixing (1), (3) to (7) and (10),
Heat to 0 ° C. and stir. B. Mix (2), (8) and (9). C. B was added to A, mixed, and then cooled to obtain a pack.

【0064】[0064]

【表15】 実施例10 洗浄料: <処方> (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 0.1 (8)防腐剤 0.2 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)アスパラガス抽出物*1 0.2 (12)N,N′−ジアセチルシスチンジメチル 0.1 (13)精製水 残量Table 10 Example 10 Cleaning agent: <Prescription> (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) ) Oleyl alcohol 1.5 (6) Purified lanolin 1.0 (7) Perfume 0.1 (8) Preservative 0.2 (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Asparagus Extract * 1 0.2 (12) N, N'-diacetylcystine dimethyl 0.1 (13) Purified water Remaining amount

【0065】<製法> A.(9)〜(10)及び(13)を混合し、70℃に
加熱する。 B.(1)〜(6)及び(8)を混合し、70℃に加熱
する。 C.AにBを加え、暫く70℃に保ち、けん化反応が終
了してから、50℃まで冷却し、(7)、(11)及び
(12)を加え、冷却して洗浄料を得た。
<Production Method> A. (9) to (10) and (13) are mixed and heated to 70 ° C. B. Mix (1) to (6) and (8) and heat to 70 ° C. C. B was added to A and maintained at 70 ° C. for a while, and after the saponification reaction was completed, it was cooled to 50 ° C., (7), (11) and (12) were added and cooled to obtain a cleaning agent.

【0066】[0066]

【発明の効果】以上詳述した如く、本発明の皮膚外用剤
は、美白効果に優れているので、日やけなどによる皮膚
の黒色化、シミ・ソバカスの防止・改善等に有効であ
る。さらに本発明の皮膚外用剤は、安定で、しかも安全
であるため、安心して使用することができる。
As described above in detail, since the external preparation for skin of the present invention has an excellent whitening effect, it is effective for blackening the skin due to sunburn and preventing / improving spots / freckles. Furthermore, since the external preparation for skin of the present invention is stable and safe, it can be used with confidence.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 C 7167−4C ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI technical display area A61K 35/78 C 7167-4C

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次の成分(A)及び(B)、(A)アス
パラガス抽出物、(B)(イ)N,N′−ジアセチルシ
スチンジメチル、又は(ロ)ヨクイニン、イブキトラノ
オ、クララ、サンザシ、ホップ、ノイバラ及びシラユリ
から選ばれる植物の抽出物の1種又は2種以上、を含有
することを特徴とする皮膚外用剤。
1. The following components (A) and (B), (A) asparagus extract, (B) (a) N, N'-diacetylcystine dimethyl, or (b) yokuinin, ibukitranoo, clara, An external preparation for skin, which comprises one or more kinds of plant extracts selected from hawthorn, hops, white roses and white lilies.
JP27884492A 1992-10-16 1992-10-16 External preparation for skin Expired - Lifetime JP3170070B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27884492A JP3170070B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27884492A JP3170070B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH06128143A true JPH06128143A (en) 1994-05-10
JP3170070B2 JP3170070B2 (en) 2001-05-28

Family

ID=17602940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27884492A Expired - Lifetime JP3170070B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3170070B2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892055A (en) * 1994-09-22 1996-04-09 Kao Corp Whitening cosmetic
JP2000007544A (en) * 1998-06-16 2000-01-11 Matsukawa Kagaku:Kk Cosmetic
JP2000256175A (en) * 1999-03-15 2000-09-19 Rasheru Seiyaku Kk Cosmetic composition
US6214352B1 (en) 2000-01-06 2001-04-10 Matsukawa Kagaku Co., Ltd. Tyrosinase inhibiting agent
EP1120407A1 (en) * 1998-10-09 2001-08-01 Ajinomoto Co., Inc. Cysteine derivatives
JP2001261570A (en) * 2000-03-22 2001-09-26 Nisshin Oil Mills Ltd:The Skin care preparation
WO2002072040A1 (en) * 2001-03-13 2002-09-19 Ajinomoto Co., Inc. Comsetics or external preparaiotns for skin
JP2005015450A (en) * 2003-06-30 2005-01-20 Kanebo Cosmetics Inc Skin cosmetic
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
JP2006111583A (en) * 2004-10-15 2006-04-27 Unitika Ltd gamma-AMINO BUTYRIC ACID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME
US7060304B2 (en) 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US8481093B2 (en) 2010-12-17 2013-07-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium candidum extracts and uses thereof
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
US10980718B2 (en) * 2016-12-21 2021-04-20 Conopco, Inc. Personal care compositions comprising poorly soluble compounds

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892055A (en) * 1994-09-22 1996-04-09 Kao Corp Whitening cosmetic
JP2000007544A (en) * 1998-06-16 2000-01-11 Matsukawa Kagaku:Kk Cosmetic
EP1120407A4 (en) * 1998-10-09 2005-02-09 Ajinomoto Kk Cysteine derivatives
EP1120407A1 (en) * 1998-10-09 2001-08-01 Ajinomoto Co., Inc. Cysteine derivatives
US7105570B2 (en) 1998-10-09 2006-09-12 Ajinomoto Co., Inc. Cysteine derivatives
JP2000256175A (en) * 1999-03-15 2000-09-19 Rasheru Seiyaku Kk Cosmetic composition
US6214352B1 (en) 2000-01-06 2001-04-10 Matsukawa Kagaku Co., Ltd. Tyrosinase inhibiting agent
JP2001261570A (en) * 2000-03-22 2001-09-26 Nisshin Oil Mills Ltd:The Skin care preparation
WO2002072040A1 (en) * 2001-03-13 2002-09-19 Ajinomoto Co., Inc. Comsetics or external preparaiotns for skin
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
US7060304B2 (en) 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US7247321B2 (en) 2003-04-16 2007-07-24 Access Business Group International Llc Skin whitening compositions containing asparagus extract
US7364759B2 (en) 2003-04-16 2008-04-29 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
JP2005015450A (en) * 2003-06-30 2005-01-20 Kanebo Cosmetics Inc Skin cosmetic
JP2006111583A (en) * 2004-10-15 2006-04-27 Unitika Ltd gamma-AMINO BUTYRIC ACID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME
US8481093B2 (en) 2010-12-17 2013-07-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising Lilium candidum extracts and uses thereof
US9421236B2 (en) 2010-12-17 2016-08-23 Johnson & Johnson Consumer Inc. Compositions comprising Lilium siberia extracts and uses thereof
US10980718B2 (en) * 2016-12-21 2021-04-20 Conopco, Inc. Personal care compositions comprising poorly soluble compounds

Also Published As

Publication number Publication date
JP3170070B2 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
JPH08283172A (en) Active oxygen scavenger and skin preparation for external use containing the scavenger
JP3170070B2 (en) External preparation for skin
JP3415200B2 (en) External preparation for skin
JPH03236322A (en) Skin drug for external use
JP3480952B2 (en) External preparation for skin
JPH03193712A (en) Cosmetic
EP1252888A1 (en) Biologically active labdane or labdene derivatives from Cistus
JPH04346911A (en) Cosmetic
JPH04338313A (en) Cosmetic
JP3480954B2 (en) External preparation for skin
JPH0812560A (en) Skin external preparation
JPH09131393A (en) Deodorant, deodorizing composition, and deodorizing cosmetic
JPH06128142A (en) External agent for skin
JPH06128145A (en) External agent for skin
JP3809003B2 (en) Whitening agent
JPH0899859A (en) Skin external agent
JPH10194982A (en) Collagenase inhibitor and skin lotion for senescence prevention containing the same
JP3397552B2 (en) Cosmetics
JPH0672838A (en) Cosmetic
JP3105664B2 (en) External preparation for skin
KR20030004499A (en) Cosmetic for skin whitening containing a herb extract with inhibitory activity of melanin formation
KR100331675B1 (en) External skin preparation
JPH049313A (en) Cosmetic
JPH04346912A (en) Cosmetic
JPH1135426A (en) Composition for head

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120316

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130316

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130316

Year of fee payment: 12